Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Austria Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20042
20061
20073
20081
20092
20112
20124
20132
20144
20151
20171
20182
20191
20216
20222
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting9
Terminated6
Recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Eli Lilly and Company5
Sanofi4
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals3
Pfizer2
AbbVie1
Amgen1
Astellas Pharma Europe Ltd.1
Australasian Gastro-Intestinal Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis44
Breast Neoplasms13
Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms5
Brain Neoplasms4
Melanoma4
Carcinoma, Renal Cell3
Neoplasms by Site3
Pancreatic Neoplasms3

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.